The pharmacological effects of monoamine potentiating antidepressants are likely to be expressed ultimately on cortical pyramidal neurones that use glutamate as a neurotransmitter. However, there are few data on the effects of antidepressant treatment on cortical glutamate levels in humans. The aim of the present study was to use proton magnetic resonance spectroscopy (MRS) to assess the effects of short-term administration of the selective serotonin re-uptake inhibitor, citalopram and the selective noradrenaline re-uptake inhibitor, reboxetine, on a composite measure of glutamate and glutamine (Glx) in occipital cortex in healthy volunteers using a parallel group, placebo-controlled design. We found that relative both to placebo and reboxetine, seven days treatment with citalopram significantly increased cortical Glx. Our data suggest that short-term treatment with citalopram, but not reboxetine, increases occipital Glx in healthy subjects. Further studies are needed to find out if similar effects occur in anterior brain regions and whether they reflect changes in glutamate or glutamine or both.
References
1.
Aghajanian G.K., Marek G. J (1999) Serotonin, via 5-HT(2A) receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res825: 161-171
2.
Bhagwagar Z., Wylezinska M., Taylor M., Jezzard P., Matthews P.M., Cowen P. J (2004) Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry161: 368-370
3.
Bonanno G., Giambelli R., Raiteri L., Tiraboschi E., Zappettini S., Musazzi L., Riateri M., Racagni G M P (2005) Chronic antidepressants reduce deplorization-evoked glutamate release and protection interactions favoring formation of SNARE complex in hippocampus. J Neurosci25: 3270-3279
4.
Bottomley P.A. (1984) PRESS sequence. US Patent, 4480228
Brunello N., Mendelwicz J., Kasper S., Leonard B., Montgomery S., Paykel E., Versiani M., Racagni G. (2002) The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur Neuropsychpharmacol12: 461-475
7.
Devilbiss D.M., Waterhouse B.D. (2000) Norepinephrine exhibits two distinct profiles of action on sensory cortical neuron responses to excitatory synaptic stimuli . Synapse37: 273-282
8.
Ferrero A.J., Cereseto M., Reines A., Bonavita C.D., Sifonios L.L., Rubio M.C., Wikinski S.I. (2005) Chronic treatment with fluoxetine decreases seizure threshold in naive but not in rats exposed to the learned helplessness paradigm: correlation with hippocampal glutamate release. Prog Neuro-Psychopharmacol29: 678-686
9.
First M.B., Spitzer R.L., Gibbon M., Williams J B W (1997) Structured Clinical Interview for DSM-IV Axis I disorders - Clinician Version (SCID-CV). American Psychiatric Press, Washington, DC
10.
Harmer C.J., Shelley N.C., Cowen P.J., Goodwin G.M. (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry161: 1256-1263
11.
Harmer C.J., Mackay C.E., Reid C.B., Cowen P.J., Goodwin G.M. (2006) Antidepressant drug treatment modifies the neural processing of non-conscious threat cues. Biol Psychiatry59: 816-820
12.
Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., Drevets W.C. (2007) Reduced prefrontal glutamate/gluatamine and γ-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry64: 193-200
13.
Junker V., Becker A., Huhne R., Zembatov M., Ravati A., Culmsee C., Krieglstein J. (2002) Stimulation of β-adrenoceptors activates astrocytes and provides neuroprotection. Eur J Pharmacol446: 25-36
14.
Kugaya A., Sanacora G. (2005) Beyond monoamines: glutamatergic function in mood disorders. CNS Spectrums10: 808-819
15.
Lyoo K., Renshaw P.F. (2002) Magnetic resonace spectroscopy: current and future applications in psychiatric research. Biol Psychiatry51: 195-207
16.
Marek G.J., Aghajanian G.K. (1999) 5-HT(2A) receptor or α-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol367: 197-206
17.
Meller R., Harrison P.J., Elliott J.M., Sharp T. (2002) In vitro evidence that 5-hydroxytryptamine increases the efflux of glial glutamate via 5-HT2A receptor activation. J Neurosci67: 399-405
18.
Mescher M., Merkle H., Kirsch J., Garwood M., Gruetter R. (1998) Simultaneous in vivo spectral editing and water suppression. NMR Biomed11: 266-272
19.
Naressi A., Couturier C., Devos J.M., Janssen M., Mangeat C., De Beer R., Graveron-Demilly D. (2001) Java-based graphical user interface for the MRUI quantitation package. Mag Res Mat Phys Biol Med12: 141-152
20.
Paul I.A., Skolncik P. (2003) Glutamate and depression: Clinical and Pre-clinical studies. Ann NY Acad Sci1003: 250-272
21.
Phillips M.L., Drevets W.C., Rauch S.L., Lane R. ( 2003) Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry54: 515-528
22.
Provencher S.W. (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med30: 672-679
23.
Rosenburg D.R., MacMaster F.P., Keshaven M.S., Fitzgerald K.D., Stewart C.M., Moore G.J. (2000) Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry39: 1096-1103
24.
Rothman D.L., Petroff O.A., Behar K.L., Mattson R.H. (1993) Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA90: 5662-5666
25.
Sanacora G., Mason G.F., Rothman D.L., Krystal J.H. (2002) Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors . Am J Psychiatry159: 663-665
26.
Vanhamme L., Van Den Boogaart A., Van Huffel S. (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Mag Res129: 35-43
27.
Zhang Y., Brady M., Smith S. (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation maximization algorithm. IEEE Trans Med Imaging20: 45-57
